close
Home
COVID-19
chevron_right
#WE-WONT-REST
chevron_right
News & Events
chevron_right
Manifesto
About medicines
chevron_right
Relationships & code
chevron_right
Publications
chevron_right
About us
chevron_right
Contact us
KMS Login
arrow_back
close
COVID-19
Member Updates
News
#WE-WONT-REST
Illness Never Sleeps
Brighter Tomorrow
For the Chance
Questions Inspire Solutions
Pledge Wall
Patient stories
Innovation
expand_more
expand_less
chevron_right
Diabetes
Alzheimer’s disease
Migraine
Blood cancers
Lung cancer
NASH
Antibacterial Monoclonal Antibodies
Haemophilia
C.difficile
News & Events
The EFPIA View
Events
Newsletter
Manifesto
About medicines
Development of medicines
expand_more
expand_less
chevron_right
Innovative Medicines Initiative (IMI)
Animal Use and Welfare
Regulations, safety & supply
Intellectual Property
Trade
Digital Health
SMEs in Europe
Use of medicines
expand_more
expand_less
chevron_right
Value of medicines
HTA & Relative Efficacy Assessment
Outcomes-focused, sustainable healthcare
Disease-specific groups
Relationships & code
The EFPIA Code
Patient organisations
Healthcare professionals (HCPs)
Disclosure of payments to HCPs
National codes
EU institutions
Publications
Data center
Downloads
Cancer Comparator Report
expand_more
expand_less
chevron_right
About
Recommendations
Cancer Cases
Cancer Deaths
Survival
Cancer Care
Cancer Types
Resources
About us
Who we are
Annual reports
EFPIA Japan
Membership
Job vacancies
Contact us
arrow_back
close
Innovation
Diabetes
Alzheimer’s disease
Migraine
Blood cancers
Lung cancer
NASH
Antibacterial Monoclonal Antibodies
Haemophilia
C.difficile
Development of medicines
Innovative Medicines Initiative (IMI)
Animal Use and Welfare
Regulations, safety & supply
Intellectual Property
Trade
Digital Health
SMEs in Europe
Use of medicines
Value of medicines
HTA & Relative Efficacy Assessment
Outcomes-focused, sustainable healthcare
Disease-specific groups
Cancer Comparator Report
About
Recommendations
Cancer Cases
Cancer Deaths
Survival
Cancer Care
Cancer Types
Resources
News & Events
The EFPIA view
Podcast: How can...
Podcast: How can we keep SMEs in Europe?
close
Podcast: How can we keep SMEs in Europe?
Welcome to 19 conversations
apps
The EFPIA View
chevron_left
Previous
print
Print
Next
chevron_right
Podcast: How can we keep SMEs in Europe?
05.11.20
Today we're asking Erik van den Berg, Chief Executive Officer, AM Pharma: How can we keep SMEs in Europe?
Listen to hear their discussion on the challenge and how we're preparing for the future.
close
continue